Related references
Note: Only part of the references are listed.Colon Cancer-Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins
Sandra Travica et al.
CLINICAL CANCER RESEARCH (2013)
Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors
Stephen J. Clarke et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Stereoselectivity of Human Cytochrome P450 in Metabolic and Inhibitory Activities
Toshiro Niwa et al.
CURRENT DRUG METABOLISM (2013)
CYP Epoxygenase Derived EETs: From Cardiovascular Protection to Human Cancer Therapy
Chen Chen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder
Mark Sutherland et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Progress in the identification of plasma biomarkers of colorectal cancer
Caroline Coghlin et al.
PROTEOMICS (2013)
The monooxygenase, peroxidase, and peroxygenase properties of cytochrome P450
Eugene G. Hrycay et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma
Dehui Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases
Ariel R. Topletz et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold
Mohamed S. Gomaa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates
Mohamed S. Gomaa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Abiraterone in Prostate Cancer: A New Angle to an Old Problem
Mark N. Stein et al.
CLINICAL CANCER RESEARCH (2012)
Novel Prognostic Biomarkers in Colorectal Cancer
Alberto Malesci et al.
DIGESTIVE DISEASES (2012)
Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative
G. C. Kabat et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2012)
Epigenetic biomarkers in colorectal cancer diagnostics
James B. Rawson et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Epigenetics of Colorectal Cancer
Ajay Goel et al.
GASTROENTEROLOGY (2012)
Lecithin: Retinol Acyltransferase Is Critical for Cellular Uptake of Vitamin A from Serum Retinol-binding Protein
Jaume Amengual et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hepatic Vitamin A Preloading Reduces Colorectal Cancer Metastatic Multiplicity in a Mouse Xenograft Model
Eun Young Park et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer
Wei Yu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Cytochrome P450s in the Regulation of Cellular Retinoic Acid Metabolism
A. Catharine Ross et al.
ANNUAL REVIEW OF NUTRITION, VOL 31 (2011)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Microsatellite Instability and Colorectal Cancer
Katherine B. Geiersbach et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
Robin K. Kelley et al.
CLINICAL COLORECTAL CANCER (2011)
Advances in Human Cytochrome P450 and Personalized Medicine
Qi Chen et al.
CURRENT DRUG METABOLISM (2011)
Cytochrome P450-dependent eicosanoid production and crosstalk
Ingrid Fleming
CURRENT OPINION IN LIPIDOLOGY (2011)
Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal
Maria Almira Correia et al.
DRUG METABOLISM REVIEWS (2011)
Colorectal cancer molecular biology moves into clinical practice
Colin C. Pritchard et al.
GUT (2011)
The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis
Nicholas R. Hope et al.
HUMAN PATHOLOGY (2011)
Biomarker Use in Colorectal Cancer Therapy
Robin K. Kelley et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis
Donna O'Dwyer et al.
PLOS ONE (2011)
Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology
F. Peter Guengerich et al.
PHARMACOLOGICAL REVIEWS (2011)
Predictive Molecular Classifiers in Colorectal Cancer
Pierre Bohanes et al.
SEMINARS IN ONCOLOGY (2011)
Predictive and Prognostic Markers in Colorectal Cancer
Ben George et al.
CURRENT ONCOLOGY REPORTS (2011)
Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cells
Christian Helvig et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2011)
Cytochrome P450-derived eicosanoids: the neglected pathway in cancer
Dipak Panigrahy et al.
CANCER AND METASTASIS REVIEWS (2010)
Biomarkers for Colorectal Cancer: Identification Through Proteomics
Lynda D. Ralton et al.
Current Proteomics (2010)
Focus on Molecules: Lecithin retinol acyltransferase
Alberto Ruiz et al.
EXPERIMENTAL EYE RESEARCH (2010)
Colorectal cancer chemoprevention: the potential of a selective approach
Oded Ben-Amotz et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Profiling the expression of cytochrome P450 in breast cancer
Graeme I. Murray et al.
HISTOPATHOLOGY (2010)
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment
Cristina Rodriguez-Antona et al.
HUMAN GENETICS (2010)
Structural diversity of cytochrome P450 enzyme system
Tsuneo Omura
JOURNAL OF BIOCHEMISTRY (2010)
Current and emerging concepts in tumour metastasis
Caroline Coghlin et al.
JOURNAL OF PATHOLOGY (2010)
Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids
Cosima Arnold et al.
PHARMACOLOGICAL REPORTS (2010)
Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase
Justin D. Lutz et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Antibodies as a Probe in Cytochrome P450 Research
Magang Shou et al.
DRUG METABOLISM AND DISPOSITION (2009)
The role of CYP26 enzymes in retinoic acid clearance
Jayne E. Thatcher et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Design and synthesis of substituted imidazole and triazole N-phenylbenzo[d]oxazolamine inhibitors of retinoic acid metabolizing enzyme CYP26
Stephane Pautus et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2009)
Novel azolyl-(phenylmethyl)]aryl/heteroarylamines:: Potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells
Mohamed Sayed Gomaa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
Kristiina M. Huttunen et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Tumour-specific expression of CYP2W1: Its potential as a drug target in cancer therapy
Maria Karlgren et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Daniel W. Nebert et al.
NATURE REVIEWS CANCER (2006)
Monoclonal antibodies and multifunctional cytochrome P450: Drug metabolism as paradigm
HV Gelboin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Profiling markers of prognosis in colorectal cancer
MS Lyall et al.
CLINICAL CANCER RESEARCH (2006)
Overview of retinoid metabolism and function
Rune Blomhoff et al.
JOURNAL OF NEUROBIOLOGY (2006)
Cytochrorne P450 profile of colorectal cancer: Identification of markers of prognosis
M Kumarakulasingham et al.
CLINICAL CANCER RESEARCH (2005)
Aromatase inhibitors in the treatment of breast cancer
RW Brueggemeier et al.
ENDOCRINE REVIEWS (2005)
Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death
M Osanai et al.
MOLECULAR PHARMACOLOGY (2005)
Inhibition of P450 17 as a new strategy for the treatment of prostate cancer
F Leroux
CURRENT MEDICINAL CHEMISTRY (2005)
Reduced lecithin: Retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer
S Boorjian et al.
CLINICAL CANCER RESEARCH (2004)
Tumour cytochrome P450 and drug activation
LH Patterson et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy
V. C. O. Njar
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2002)
Regulation, function, and tissue-specific expression of cytochrome P450CYP1B1
GI Murray et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Share Paper
